Sanoculis Ltd.
À propos de votre organisation / profil
Sanoculis Ltd. is an emerging growth Isaeli-based startup which develops and markets a disruptive technology for the treatment of Glaucoma.
Glaucoma is a leading cause of irreversible blindness affecting globally over 130 million people. The market for Glaucoma devices solutions demonstrated 33% annual growth in recent years with an estimated total accessible market (TAM) of $1.4B in 2023
Sanoculis’ core and proprietary technology is MIMS® - a stent-less, fast, safe and CE marked system for Glaucoma treatment
To date, over 110 patients received the Sanoculis’ treatment
Sanoculis is collaborating with Appasamy, India’s largest ophthalmic equipment manufacturer and distributor, to adapt, manufacture and distribute MIMS® in India.
Sanoculis plans to raise $12M in Round B financing to complete large post-market studies and get US FDA and China CFDA approvals
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
